An amendment numbered 12 printed in Part B of House Report 116-334 to increase funding for clinical trials at NIH and ban the use of spread pricing by PBMs as it relates to Medicaid.

Ask AI
Amendment Number
722
Description
An amendment numbered 12 printed in Part B of House Report 116-334 to increase funding for clinical trials at NIH and ban the use of spread pricing by PBMs as it relates to Medicaid.
Purpose
An amendment numbered 12 printed in Part B of House Report 116-334 to increase funding for clinical trials at NIH and ban the use of spread pricing by PBMs as it relates to Medicaid.
Congress
116
Type
HAMDT
Latest Action Date
Dec 12, 2019
Latest Action Text
On agreeing to the Houlahan amendment (A012) Agreed to by voice vote.
Latest Action Time
12:46:30
Submitted Date
Dec 12, 2019
Chamber
House of Representatives
Update Date
Feb 8, 2022
Amendment 722 — Informed